Comparing ED Treatment Options: Oral Medications, Injections, Devices, and Surgery

Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. All opinions remain our own.

Disclaimer: This article is for informational and educational purposes only and is not intended as medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Erectile dysfunction is a medical condition that requires evaluation by a qualified healthcare provider. The information presented here is based on publicly available data and should not be used to self-diagnose or self-help manage. Always consult your physician before starting any treatment for erectile dysfunction, especially if you have cardiovascular disease, take nitrate medications, or have other health conditions. Individual results vary significantly based on underlying health status, medication interactions, and other factors. This article contains references to prescription medications that require physician authorization.

ED Treatment Comparison: Understanding Your Options in March 2026

Last Updated: April 2026

If you're researching ED treatment comparison options, you're not alone. Erectile dysfunction affects approximately 30 million men in the United States, and treatment approaches have evolved significantly in recent years. The landscape now includes oral medications, injectable therapies, vacuum devices, surgical implants, and emerging telehealth platforms that combine multiple pharmaceutical approaches.

This analysis examines the primary erectile dysfunction treatment options available in 2026. We'll break down how each category works, what the clinical evidence shows, and what factors determine which approach might be appropriate for different situations. The goal is to provide the context you need for an informed conversation with your healthcare provider.

The treatment you choose depends on the underlying cause of ED, your overall health status, current medications, and personal preferences. There's no universal “best” option—only the most appropriate option for your specific medical situation.

How Oral ED Medications Work: The PDE5 Inhibitor Category

Oral medications remain the most commonly prescribed first-line treatment for erectile dysfunction. These drugs belong to a class called phosphodiesterase type 5 (PDE5) inhibitors. They work by blocking an enzyme that breaks down cyclic guanosine monophosphate (cGMP), a molecule that relaxes smooth muscle tissue in blood vessels.

When cGMP levels remain elevated, blood vessels in erectile tissue can dilate more effectively in response to sexual stimulation. This doesn't create an automatic response—sexual arousal is still required. The medication simply enhances the body's natural physiological process.

Four FDA-approved PDE5 inhibitors are currently available:

Sildenafil (Viagra®): The first PDE5 inhibitor approved in 1998. According to research by Ashour et al., sildenafil typically begins working within 30-60 minutes and remains effective for 4-6 hours. Food intake, particularly high-fat meals, can delay absorption and reduce effectiveness.

Tadalafil (Cialis®): A 2024 study published in Journal of the American College of Cardiology by Grünig et al. examined tadalafil's extended duration. The medication can remain effective for up to 36 hours, which allows for more spontaneous timing compared to shorter-acting options. It's also available in a low-dose daily formulation.

Vardenafil (Levitra®): According to a 2014 review in Profiles of Drug Substances, Excipients, and Related Methodology by Ashour et al., vardenafil demonstrates rapid onset similar to sildenafil but may be less affected by food intake. Clinical trials showed effectiveness in diabetic and post-prostatectomy patients.

Avanafil (Stendra®): The newest FDA-approved PDE5 inhibitor, designed for faster onset—potentially as quick as 15 minutes in some patients. Duration is similar to sildenafil at approximately 6 hours.

All PDE5 inhibitors share similar side effect profiles: headache, flushing, nasal congestion, and visual disturbances. They're contraindicated with nitrate medications due to dangerous blood pressure interactions. Your physician needs a complete medication list before prescribing any PDE5 inhibitor.

Compounded Multi-Ingredient Formulations: A Newer Approach

Some telehealth platforms now offer compounded formulations that combine multiple active ingredients in a single dose. QUAD by MEDVI represents this category—a physician-prescribed compounded medication containing apomorphine, vardenafil, tadalafil, and sildenafil in sublingual liquid form.

The rationale behind combination therapy is that different ingredients may address different aspects of erectile function. According to the manufacturer, the sublingual delivery method bypasses first-pass metabolism in the liver, potentially allowing faster onset than swallowed pills. The company states the formulation can begin working in 10-15 minutes while providing extended duration from the tadalafil component.

It's important to understand the regulatory distinction here. FDA-approved medications like Viagra® and Cialis® undergo extensive clinical trials proving safety and efficacy for their approved indications. Compounded medications are prepared by licensed pharmacies under state pharmacy board oversight but don't go through the same FDA approval process for the specific combination.

A 2025 study published in EClinicalMedicine by Sanz et al. examined apomorphine (one of the ingredients in compounded formulations) for neurological conditions. The research found apomorphine acts as a dopamine agonist, which may influence sexual desire through central nervous system pathways—a different mechanism than PDE5 inhibitors' vascular effects.

Compounded formulations aren't typically covered by insurance, which makes them more expensive than generic PDE5 inhibitors. According to the MEDVI website, pricing starts at $119-179 per month as of March 2026. Generic sildenafil or tadalafil through traditional pharmacies with insurance coverage often costs significantly less.

If you're considering a compounded option, ask your prescribing physician about the specific dosages of each ingredient, potential drug interactions, and how this approach compares to FDA-approved single-ingredient medications for your situation. For more context on how MEDVI's telehealth model works, see our QUAD by MEDVI Review: Telehealth ED Treatment Analysis.

If you're considering a compounded ED formulation through a telehealth platform, understanding the regulatory framework and safety considerations is as important as understanding the medication itself. Our compounded ED medication safety guide covers the FDA oversight framework, drug interaction specifics, and a practical checklist to use before enrolling in any program. And for men who have been using standard PDE5 inhibitors but are seeing diminishing results, our guide to why PDE5 inhibitors stop working covers the full escalation pathway from dose adjustment through combination therapy.

Injectable ED Medications: When Oral Options Aren't Effective

For men who don't respond to oral medications or can't take them due to contraindications, injectable therapies offer an alternative. These medications are injected directly into the base or side of the penis 5-20 minutes before sexual activity.

The most common injectable is alprostadil (Caverject®, Edex®), a prostaglandin E1 analog that directly relaxes smooth muscle in erectile tissue and dilates blood vessels. Unlike PDE5 inhibitors, alprostadil doesn't require sexual stimulation to produce an erection—the medication creates a mechanical response.

Some physicians prescribe “bi-mix” or “tri-mix” compounded injectable formulations containing combinations of alprostadil, phentolamine, and papaverine. These aren't FDA-approved combinations but are commonly used in urology practice.

Injectable medications have higher efficacy rates than oral options—studies show response rates of 70-90% compared to 60-70% for PDE5 inhibitors. However, the injection process itself is a barrier for many men. Side effects include pain at the injection site, prolonged erection (priapism, which requires emergency treatment), and potential scarring with long-term use.

Injectables work well for men with severe vascular damage, diabetes-related ED, or post-prostatectomy cases where oral medications prove insufficient. They require proper training from a urologist on injection technique and dosing.

Vacuum Erection Devices: Non-Pharmaceutical Mechanical Support

Vacuum erection devices (VEDs) are manufactured in an FDA-registered facility and follows Good Manufacturing Practice (GMP) standards mechanical treatments that don't involve medication. The device creates negative pressure around the penis, drawing blood into erectile tissue. A constriction ring placed at the base maintains the erection by preventing blood from flowing back out.

VEDs are effective for many men and have the advantage of no systemic drug interactions. They're often covered by insurance, especially for post-prostatectomy rehabilitation. The main disadvantages are the mechanical nature of the process (which some find unnatural), potential bruising, and the need to remove the constriction ring within 30 minutes to prevent tissue damage.

Clinical data shows VEDs can be particularly useful in combination with other treatments or as a rehabilitation tool after prostate surgery. They're also an option for men who can't take any ED medications due to cardiovascular contraindications.

Penile Implants: Surgical Solutions for Refractory Cases

When conservative treatments fail or aren't suitable, penile prosthesis surgery offers a permanent solution. Two main types exist: inflatable implants and malleable (semi-rigid) implants.

Inflatable implants consist of cylinders placed in the erectile chambers, a fluid reservoir in the abdomen, and a pump in the scrotum. The patient activates the pump to transfer fluid into the cylinders, creating an erection. Deflation reverses the process. Three-piece inflatable implants provide the most natural appearance and function.

Malleable implants are simpler—bendable rods that remain semi-rigid. The penis is positioned upward for intercourse and downward for concealment. These are easier to operate but less natural in appearance.

Satisfaction rates for penile implants are high among men who choose this option—studies report 90%+ satisfaction in properly selected patients. However, this is irreversible surgery with risks including infection, mechanical failure, and erosion. It's typically reserved for men who've exhausted other options or have anatomical issues preventing other treatments from working.

Recovery takes 4-6 weeks, and the implant must be activated regularly to prevent capsule formation. Cost is significant, though Medicare and most insurance plans cover the procedure when medically necessary.

Understanding the Vascular and Neurological Basis of ED Treatment Selection

The most appropriate treatment depends on what's causing erectile dysfunction in the first place. ED results from disruption in one or more of these systems: vascular (blood flow), neurological (nerve signaling), hormonal, or psychological.

Vascular ED—caused by atherosclerosis, diabetes, or hypertension—is the most common type. PDE5 inhibitors work well here because they enhance the vascular response. If vascular damage is severe, injectables that bypass the natural signaling pathway may be more effective.

Neurological ED—from spinal cord injury, multiple sclerosis, or nerve damage during pelvic surgery—often requires higher doses of medication or injectable therapy. The nerve signals that trigger the vascular response are impaired, so medications that directly stimulate smooth muscle relaxation work better.

For a detailed explanation of how these mechanisms work, see our article on How Erectile Dysfunction Develops: Vascular and Neurological Mechanisms.

Hormonal ED—from low testosterone or thyroid disorders—may require hormone replacement in addition to ED medications. Psychological ED—from anxiety, depression, or relationship issues—often responds to counseling combined with medication to reduce performance anxiety.

Your physician should conduct a thorough evaluation to identify the underlying cause before recommending treatment. This typically includes medical history, physical exam, blood work to check testosterone and other hormones, and sometimes specialized testing like penile Doppler ultrasound to assess blood flow.

Comparing Effectiveness: What Clinical Data Shows About Success Rates

When evaluating ED medication effectiveness, it's important to understand that “success” is defined differently across studies. Some measure ability to achieve penetration, others measure ability to maintain erection until completion, and still others use patient-reported satisfaction scores.

PDE5 inhibitors show response rates of 60-70% in most clinical trials. This means 60-70% of men experience improvement sufficient for sexual activity. Response rates are lower in difficult-to-help manage populations like diabetics (40-60%) or post-prostatectomy patients (30-50%).

Injectable medications demonstrate higher efficacy—70-90% response rates—because they bypass the natural signaling pathway. The tradeoff is the invasive nature of the treatment.

Vacuum devices show success rates of 60-80% when measured by ability to achieve erection adequate for penetration. User satisfaction is more variable because the mechanical process affects spontaneity.

Penile implants have the highest “success” rates (90%+) in terms of ability to achieve erection on demand, but this is a surgical intervention with different risk-benefit considerations than medical therapy.

It's also worth noting that “failure” of first-line treatment doesn't mean the condition is untreatable. Many men who don't respond to one PDE5 inhibitor respond to another. Dose optimization, timing adjustments, and addressing underlying health issues can improve outcomes.

Surgical vs Nonsurgical ED Treatment: When to Consider Each Path

The decision between surgical vs nonsurgical ED treatment follows a stepwise approach in most urology practices. Conservative options are tried first, progressing to more invasive interventions only when necessary.

Nonsurgical treatments include:

• Lifestyle modifications (weight loss, exercise, smoking cessation)
• Oral PDE5 inhibitors
• Compounded oral or sublingual formulations
• Vacuum erection devices
• Injectable medications
• Intraurethral suppositories (less commonly used)

Surgical options include:

• Penile prosthesis implantation
• Vascular surgery (rarely performed, only for specific anatomical issues)

Surgery is typically considered when:

• Multiple medication trials have failed at optimized doses
• Injectable therapy is ineffective or not tolerated
• The patient has anatomical abnormalities (severe Peyronie's disease, priapism damage)
• The patient prefers a permanent solution and understands the irreversibility

The key factor is that penile implant surgery destroys remaining natural erectile tissue. Once you have an implant, you can't go back to medication-based approaches. This makes it a final-stage option rather than a first-line treatment.

Age, overall health, and life expectancy also factor into the decision. A 45-year-old in excellent health might choose an implant after exhausting other options. A 75-year-old with significant cardiovascular disease might prefer less invasive approaches even if effectiveness is lower.

Cost Comparison: Insurance Coverage and Out-of-Pocket Expenses in 2026

Treatment costs vary dramatically depending on insurance coverage, generic vs brand-name medications, and whether you use traditional pharmacies or telehealth platforms.

Generic PDE5 inhibitors (sildenafil, tadalafil) cost $10-40 per month with insurance at traditional pharmacies. Without insurance, prices range from $30-200 per month depending on dosage and quantity. GoodRx and similar discount programs can reduce costs significantly.

Brand-name medications (Viagra®, Cialis®) cost $400-600 per month without insurance. Insurance coverage varies—some plans cover ED medications, others don't. Medicare Part D plans have different formularies.

Telehealth platforms offering compounded formulations typically charge $119-240 per month as of March 2026. These aren't usually covered by insurance because they're compounded medications rather than FDA-approved products. The MEDVI QUAD program lists pricing at $119-179 per month according to their website, which includes physician consultation and shipping.

Injectable medications cost $200-600 per month depending on dosage and frequency. Insurance coverage is better for injectables than oral medications in some cases, particularly when documented as medically necessary after oral medication failure.

Vacuum erection devices cost $300-500 for FDA-approved models. Many insurance plans cover VEDs, especially for post-surgical rehabilitation. This is a one-time cost rather than ongoing monthly expense.

Penile implant surgery costs $15,000-25,000. Medicare and most commercial insurance plans cover the procedure when medically necessary (documented failure of conservative treatments). Out-of-pocket costs depend on your deductible and coinsurance.

When comparing costs, factor in the effectiveness rate. A $20/month generic medication with 65% effectiveness might be more cost-effective than a $150/month compounded formulation with similar results. Conversely, if you've failed multiple oral medications, the higher cost of injectables may be justified by superior efficacy.

Who Should Consider Telehealth ED Platforms vs Traditional Urology Care

Telehealth platforms for ED treatment have grown significantly, offering convenience and privacy. But they're not appropriate for everyone. Understanding when telehealth works well and when in-person urology care is necessary helps you make the right choice.

Telehealth may be appropriate if:

• You have straightforward ED without complex medical history
• You've used PDE5 inhibitors before and know they work for you
• You don't have significant cardiovascular disease
• You're looking for convenience and lower cost than traditional office visits
• You understand the limitations of remote evaluation

Traditional in-person urology care is better if:

• You've never been evaluated for ED before
• You have complex medical history (heart disease, diabetes, neurological conditions)
• You've failed multiple oral medications and need second-line treatments
• You have anatomical concerns (Peyronie's disease, penile curvature)
• You need diagnostic testing (Doppler ultrasound, hormone panels, etc.)
• You're considering surgical options

Telehealth platforms typically offer questionnaire-based evaluations reviewed by physicians who then prescribe medication if appropriate. This works well for men with uncomplicated ED who simply need a prescription. It doesn't replace thorough urological evaluation for complex cases.

Some men use telehealth for initial treatment and then see a urologist if the medication doesn't work. Others prefer starting with in-person evaluation to get a complete workup. Both approaches can be valid depending on your situation.

The key question is whether remote evaluation provides enough information for safe prescribing in your specific case. Men with significant cardiovascular disease, multiple medications, or previous treatment failures generally benefit from in-person assessment.

Frequently Asked Questions About ED Treatment Options

How much are MEDVi pills?

According to the MEDVI website, QUAD pricing starts at $119-179 per month as of March 2026. This includes physician consultation, the compounded medication, and shipping. The exact price depends on whether you choose monthly subscription or multi-month bundles. These compounded formulations typically aren't covered by insurance, so this represents out-of-pocket cost. For comparison, generic sildenafil or tadalafil through traditional pharmacies with insurance often costs $10-40 per month.

What is the success rate of MEDVi?

MEDVI doesn't publish clinical trial data on success rates for their compounded QUAD formulation. The individual ingredients (sildenafil, tadalafil, vardenafil) have established efficacy rates of 60-70% in FDA approval studies for their single-ingredient forms. However, the specific combination, dosages, and sublingual delivery method used in QUAD haven't undergone the same level of clinical trial scrutiny. Individual results vary significantly based on the underlying cause of ED, overall health status, and other medications. The company offers a qualification process where a physician reviews your case before prescribing.

What is the best and most effective ED treatment?

There's no universal “best” ED treatment—only the most appropriate treatment for your specific medical situation. PDE5 inhibitors (sildenafil, tadalafil, vardenafil) are first-line therapy for most men with a 60-70% response rate. Injectable medications show higher efficacy (70-90%) but are more invasive. Penile implants have 90%+ satisfaction rates but require surgery. The “best” treatment depends on the underlying cause of your ED, your overall health, current medications, personal preferences, and how you respond to initial therapy. Many men try oral medications first and progress to other options only if needed.

Will telehealth be covered in 2026?

Insurance coverage for telehealth services varies significantly by plan and state. Many insurance plans now cover telehealth consultations at the same rate as in-person visits, particularly after coverage expansions during 2020-2023. However, coverage for the medications prescribed through telehealth depends on whether they're FDA-approved drugs on your plan's formulary or compounded medications. Generic PDE5 inhibitors prescribed via telehealth are often covered if they would be covered through traditional prescribing. Compounded multi-ingredient formulations like QUAD typically aren't covered because they're not FDA-approved products. Check with your specific insurance plan about telehealth consultation coverage and medication formulary.

Can you take multiple PDE5 inhibitors at the same time?

Taking multiple PDE5 inhibitors simultaneously isn't recommended in standard medical practice. These medications work through the same mechanism (blocking the PDE5 enzyme), so combining them increases the risk of side effects—particularly dangerous blood pressure drops—without necessarily improving effectiveness proportionally. Some compounded formulations contain multiple PDE5 inhibitors in a single dose, but this approach hasn't been studied in large-scale clinical trials the way single-ingredient medications have been evaluated. If one PDE5 inhibitor isn't effective at optimized dosing, switching to a different one or trying a different treatment category is the typical medical approach rather than combining multiple drugs from the same class.

How long should you try oral ED medications before considering other options?

Most urologists recommend trying oral PDE5 inhibitors at least 6-8 times at the optimal dose before concluding they're ineffective. Many men don't respond on the first attempt due to incorrect dosing, poor timing, or performance anxiety. If you've tried multiple PDE5 inhibitors (sildenafil, tadalafil, vardenafil) at maximum doses with proper timing and still don't get adequate response, that's when second-line treatments like injectable medications or vacuum devices are considered. Your physician should also evaluate whether underlying health issues (uncontrolled diabetes, low testosterone, severe vascular disease) are limiting medication effectiveness—helping manage these conditions may improve response to oral therapy.

Making an Informed Decision: Next Steps for ED Treatment Evaluation

Choosing the right ED treatment requires understanding your options, knowing the underlying cause of your erectile dysfunction, and working with a qualified healthcare provider to match treatment to your specific situation.

If you haven't been evaluated yet, start with a detailed assessment. This should include medical history, physical examination, blood work to check testosterone and other relevant markers, and discussion of current medications. Many cases of ED have treatable underlying causes—addressing these directly can improve erectile function.

For men with straightforward ED and no complex medical issues, oral PDE5 inhibitors remain the first-line approach. Generic options are cost-effective and well-studied. If standard oral medications don't work or you're looking for faster onset or longer duration, newer options like compounded formulations or different delivery methods may be worth discussing with your physician.

For men who've failed oral therapy, don't assume the condition is untreatable. Injectable medications, vacuum devices, and ultimately surgical implants provide effective alternatives. The progression through treatment options should be systematic, starting with the least invasive approaches and advancing only when necessary.

Cost, convenience, and insurance coverage all factor into the decision, but safety and effectiveness should be the primary considerations. The cheapest option that doesn't work isn't a good value. The most convenient option that creates dangerous drug interactions isn't worth the risk.

Remember that ED is often an early warning sign of cardiovascular disease. Men who develop erectile dysfunction should have their cardiovascular risk factors evaluated—this isn't just about sexual function, it's about overall health. helping manage ED appropriately while addressing underlying vascular health can improve both quality of life and long-term health outcomes.

For additional context on age-related factors that contribute to ED, see our analysis of Why Erectile Dysfunction Becomes More Common After 40: Age-Related Vascular Changes.

Individual results vary significantly. The information in this article is based on published research and manufacturer-provided data. It should not be used to self-diagnose or self-help manage. Erectile dysfunction treatment requires physician evaluation and prescription. Always consult a qualified healthcare provider before starting any ED treatment, especially if you have cardiovascular disease, take nitrate medications, or have other significant health conditions.

About This Publication

TriCountyUrology.org is a health information website and online research publication. We are not a medical practice, hospital, clinic, or healthcare facility. We do not provide medical advice, diagnoses, or treatment recommendations. Our editorial team analyzes publicly available information about health products and medical services to help readers make informed decisions in consultation with their healthcare providers.

This article contains references to prescription medications and medical devices. All treatment decisions should be made in consultation with a qualified healthcare provider who has access to your complete medical history. The content presented here is for educational purposes and should not replace professional medical consultation.

Research Sources: This analysis incorporates data from peer-reviewed studies published in Journal of Parkinson's Disease (2025), EClinicalMedicine (2024), Journal of the American College of Cardiology (2024), Profiles of Drug Substances, Excipients, and Related Methodology (2014), Clinics São Paulo Brazil (2025), and manufacturer-provided product information. Individual study citations are provided throughout the article.

Author: James Griffin, Health Content Writer | TriCountyUrology.org Editorial Team